Establishment of a Screening model for the anti-inflammation inhibitors acting on the dimerization of MyD88 TIR

Progress in Biochemistry and Biophysics

Volumn 39, Issue 5, 2012, Pages 483-490

  Zhao, Yan ^a,b   Xue, Yan ^a   Jiang, Xue ^a   Zeng, Xian Lu ^a   Ba, Xue Qing ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b Center of Disease Control   (China)

Author keywords

Anti inflammation inhibitor; Dimerization; MyD88 tir; Screening

Indexed keywords

EID: 84865012560     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2011.00379     Document Type: Article

References (18)

1. O'Neill L A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev, 2008, 226(1): 10-18
2. Sun B, Han D S. Prog Biochem Biophys, 2009,36(12): 1516-1522
3. O'Neill L A, Bowie A G. The family of five: TIR-domain containing adaptors in Toll-like receptor signalling. Nat Rev Immunol, 2007, 7(5): 353-364
4. Watters T M, Kenny E F, O'Neill L A. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol, 2007,85(6): 411-419 (Pubitemid 47367505)
5. Lord K A, Hoffman-Liebcrmann B, Liebermann D A. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL-6. Oncogene, 1990,5(7): 1095-1097
6. Xue Y, Liu L L, He F, et al. Prog Biochem Biophys, 2011, 38(4): 311-319
7. Takeda K, Akira S. TLR signaling pathways. Semin Immunol, 2004,16(1): 3-9 (Pubitemid 38147427)
8. Leung B P, Culshaw S, Gracie J A, et al. A role for IL-18 in neutrophil activation. J Immunol, 2001,167(5): 2879-2886 (Pubitemid 32768922)
9. Favilli F, Anzilotti C, Martinelli L, et al. IL-18 activity in systemic lupus erythematosus. Ann N Y Acad Sci, 2009,1173: 301-309
10. Rothe H, Jenkins N A, Copeland N G, et al. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest, 1997, 99(3): 469-474 (Pubitemid 27414804)
11. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res, 2008, 79(3): 360-376
12. Davis C N, Mann E, Behrens M M, et al. MyD88-dependent and -independent signaling by IL-I in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-Ioop mimetics. Proc Natl Acad Sei USA, 2006,103(8): 2953-2958
13. Loiarro M, Sette C, Gallo G, et al. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1 -dependent activation of NF- {kappa}B. J Biol Chem, 2005, 280 (16): 15809-15814 (Pubitemid 40616701)
14. Loiarro M, Capolunghi F, Fanto N, et al. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAKI and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol, 2007, 82(4): 801-810 (Pubitemid 47511039)
15. Mahajan N P, Linder K, Berry G, et al. Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nat Biotechnol, 1998, 16(6): 547-552 (Pubitemid 28269812)
16. Xu X, Gerard A L, Huang B C, et al. Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res, 1998, 26(8): 2034-2035 (Pubitemid 28291741)
17. He L, Wu X, Meylan F, et al. Monitoring caspase activity in living cells using fluorescent proteins and flow cytometry. Am J Pathol, 2004,164(6): 1901-1913 (Pubitemid 38669340)
18. Jones J, Heim R, Hare E, et al. Development and application of a GFP-FRET intracellular caspase assay for drug screening. J Biomol Screen, 2000,5(5): 307-318